<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="retraction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2026.9173</article-id>
<article-id pub-id-type="publisher-id">OR-56-4-09173</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] MicroRNA-365 inhibits proliferation, migration and invasion of glioma by targeting PIK3R3</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Yonggang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Hongguang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Rao</surname><given-names>Min</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Songbai</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>10</month><year>2026</year></pub-date>
<pub-date pub-type="epub"><day>27</day><month>07</month><year>2026</year></pub-date>
<volume>56</volume>
<issue>4</issue>
<elocation-id>168</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2026 Zhu et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 37: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="37" page="2185" id="RA1" xlink:href="10.3892/or.2017.5458" ext-link-type="doi">2185&#x2013;2192</related-article>, 2017; DOI: 10.3892/or.2017.5458</p>
<p>Following the publication of the above article, a concerned reader drew to the Editor&#x0027;s attention that western blot data featured in Fig. 5D were apparently the same as those featured in a different research article by the same group in the journal American Journal of Translational Research. In addition, various of the western blot data featured in Figs. 5, 6 and 7, and the cell migration and invasion assay data in Fig. 2C and D, were strikingly similar to data that were featured in other papers written by different authors at different research institutes, some of which have since been retracted, including a pair published in 2014/2015 in the journal PLoS One.</p>
<p>Given the fact that the contentious data mentioned above had been included in articles published by other research groups in different journals before this paper was received at Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
